SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Brian Moore who wrote (17646)3/18/1998 8:32:00 PM
From: Hippieslayer  Read Replies (1) | Respond to of 32384
 
The idea is to not put all of your money into lgnd. I don't think there is anything wrong with "allocating" a portion of one's money for shares of lgnd.



To: Brian Moore who wrote (17646)3/18/1998 8:33:00 PM
From: dwight martin  Read Replies (1) | Respond to of 32384
 
LGND will not just go from 16 to 90 in one day.

Brian, lots of people on this thread have graduated from high school, are investing their own $$, and are not playing with Pop's computer. Give us a break. If you think people here are waiting for a double in a week, even, you're dumber than you think we are.

AFTER EDIT: If you are looking for such a thread, go to ISCO.



To: Brian Moore who wrote (17646)3/18/1998 8:55:00 PM
From: Flagrante Delictu  Read Replies (1) | Respond to of 32384
 
Brian >> ...miss opportunities in companies that are much better positioned to break out & produce fantastic returns<<. Kindly inform us which companies these are. Bernie



To: Brian Moore who wrote (17646)3/18/1998 11:35:00 PM
From: Russian Bear  Respond to of 32384
 
Brian,

What ever gave you the idea that the "long-term" LGND investors here are looking for a doubling or tripling of the stock within a one-day or one-week period? Isn't that the very antithesis of a long-term outlook? Since when does a stock need to double overnight to be a good investment? Stocks that do that are, in fact, very seldom good long-term plays. (As a matter of fact, over the last two trading days, I made a very, very handsome profit *shorting* a stock that *did* double the previous day -- Nymox Pharm., NYMXF.)

It is my practice, for example, to invest in what I perceive to be value plays. Value plays can take many forms: a price-to-book ratio below 1.0 is not the only valid measurement. Biotech companies like LGND, with solid science, a wealth of patents and numerous compounds in the pipeline, also represent unrecognized value.

Earnings growth, by the way, is currently in favor, I realize. That was not always the case, you know. My sincere congratulations to all the "investors" out there who have multiplied several-fold their investments in the current crop of momentum darlings (AOL, YHOO, DELL, AMZN, etc.) There are those of us who would not touch such stocks with the proverbial ten-foot-pole, except from the short side (and have the scars to prove it -- ouch!) Just remember that all tulip-manias end, eventually. A well-known Wall Street quote is, "In bear markets, money returns to its rightful owners."

When you say that LGND is an inferior investment for the long term, it is my considered opinion that you are quite wrong.

No hard feelings. Good luck to you,
RB